MASTERINVEST Kapitalanlage GmbH
Source: SEC Form 13F · as of Mar 2026MASTERINVEST Kapitalanlage GmbH holds 20 biotech & pharma companies tracked by BioSniper, totaling $85.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$85.1M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 24,242 | $22.3M |
| ABBVAbbVie Inc. | 73,881 | $16.1M |
| JNJJOHNSON & JOHNSON | 33,629 | $8.2M |
| ABTABBOTT LABORATORIES | 66,962 | $6.9M |
| MRKMerck & Co., Inc. | 44,247 | $5.3M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 8,293 | $3.7M |
| GILDGILEAD SCIENCES, INC. | 25,354 | $3.5M |
| AMGNAMGEN INC | 9,894 | $3.5M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 11,400 | $3.1M |
| REGNREGENERON PHARMACEUTICALS, INC. | 2,737 | $2.1M |
| PMPhilip Morris International Inc | 12,487 | $2.1M |
| PFEPFIZER INC | 57,402 | $1.6M |
| CORCencora Inc. | 4,939 | $1.6M |
| MCKMcKesson Corporation | 1,550 | $1.3M |
| ELVElevance Health Inc. | 3,145 | $921K |
| ZTSZoetis Inc. | 7,590 | $897K |
| INSMINSMED Inc | 4,640 | $759K |
| BMYBRISTOL MYERS SQUIBB CO | 9,097 | $552K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,179 | $390K |
| GMOptec International, Inc. | 3,810 | $284K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.